SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-164566
Filing Date
2023-06-09
Accepted
2023-06-09 17:18:00
Documents
12
Period of Report
2023-06-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d501518d8k.htm   iXBRL 8-K 33064
  Complete submission text file 0001193125-23-164566.txt   154287

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rptx-20230609.xsd EX-101.SCH 2510
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20230609_lab.xml EX-101.LAB 17954
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20230609_pre.xml EX-101.PRE 11222
6 EXTRACTED XBRL INSTANCE DOCUMENT d501518d8k_htm.xml XML 3512
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 231006346
SIC: 2834 Pharmaceutical Preparations